阿迪波龙通过AMPK介导的代谢重编程和亡诱导抑制多发性骨髓瘤的扩散
Zhaohui Wang1, Xiaotian Su2,3, Ruru Guo2,3
1Department of Pharmacy, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
阿迪波龙 (AdipoRon) 是一种向阿迪波涅克丁受体的激素,在治疗多发性骨髓瘤 (MM) 中表现有前途. 它通过AMPK途径通过重编程新陈代谢来抑制MM细胞生长并诱导细胞亡.
科学领域:
- 血液学恶性瘤是什么
- 分子生物学分子生物学
- 代谢途径 代谢途径
背景情况:
- 多发性骨髓瘤 (MM) 是一种无法治愈的血液癌症,需要新的治疗方法.
- 亚迪波涅丁受体 (ADIPOR1,ADIPOR2) 和它们的激动剂阿迪波龙是潜在的治疗点.
研究的目的:
- 为了研究MM中阿迪波内克丁受体的临床相关性.
- 评估AdipoRon的抗髓瘤功效和机制.
主要方法:
- 对MM患者数据集的生物信息分析 (GSE124489,GSE187009).
- 在体外研究中,使用用AdipoRon治疗的MM细胞系 (U266,RPMI8226) 进行了研究.
- 对亡,细胞周期和关键信号通路 (AMPK,AKT,ACC) 的评估.
主要成果:
- 在MM患者中,ADIPOR1和ADIPOR2的下调;低ADIPOR1预测预后不佳.
- 阿迪波抑制了MM细胞的增殖,诱导了亡,并导致G0/G1细胞周期停止.
- 阿迪波激活了AMPK,抑制了AKT,并抑制了乙烯基-CoA碳酸酶 (ACC),破坏了脂肪酸代谢.
结论:
- 通过诱导亡和代谢重编程,AdipoRon表现出显著的抗髓瘤活性.
- 该AMPK/ACC通路对于阿迪波龙的抗MM作用至关重要.
- 阿迪波涅克丁受体激应是一种潜在的治疗策略,用于多发性骨髓瘤.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
相关概念视频
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity
